Related Experiment Videos
Cushing's syndrome with intermittent ectopic ACTH production
A van Coevorden1, E Laurent, F Rickaert
1Department of Endocrinology, Free University of Brussels, Belgium.
This report details a rare case of a 72-year-old woman with Cushing's syndrome caused by an ectopic tumor that released hormones in an unpredictable, intermittent pattern. Because the tumor was hidden and hormone levels fluctuated between normal and high, doctors faced significant challenges in reaching a diagnosis. Although initial imaging pointed toward the liver, detailed post-mortem analysis eventually identified the primary source of the hormone production in the pancreas.
Area of Science:
- Endocrinology research within Cushing's syndrome clinical practice
- Diagnostic oncology and pathology
Background:
The clinical presentation of fluctuating hormone levels in patients with suspected endocrine disorders remains a significant diagnostic hurdle. No prior work had resolved the specific challenges posed by tumors that secrete hormones in an erratic, non-continuous fashion. It was already known that ectopic adrenocorticotropic hormone production typically leads to persistent hypercortisolism. That uncertainty drove clinicians to struggle when hormone markers appeared normal during dormant phases. Prior research has shown that standard suppression tests often fail to identify occult sources of hormone excess. This gap motivated a detailed examination of a patient whose biochemical profile shifted unpredictably over ten months. Understanding these intermittent patterns is vital for avoiding misdiagnosis in elderly populations. The rarity of such cases necessitates a thorough review of diagnostic pathways and imaging limitations.
Purpose Of The Study:
The aim of this report is to document the diagnostic complexities associated with a case of ectopic ACTH syndrome characterized by intermittent secretion. This study addresses the difficulty of managing patients whose hormone levels fluctuate unpredictably over time. That uncertainty drove the need to evaluate how occult tumors can evade standard detection methods. No prior work had resolved the specific diagnostic pathway for a patient with such erratic biochemical profiles. The researchers sought to illustrate the limitations of current imaging and suppression tests in this specific clinical context. By detailing the patient's ten-month history, the authors provide insight into the pitfalls of relying on single-point measurements. This gap motivated a thorough investigation into the primary tumor site through both biopsy and post-mortem analysis. The study intends to inform clinical practice regarding the potential for non-continuous hormone release in elderly patients.
Main Methods:
Review approach involved a longitudinal analysis of a single patient case over a ten-month duration. The clinical team collected serial plasma and urinary samples to track cortisol fluctuations. Investigators applied high-dose dexamethasone suppression protocols to assess feedback sensitivity during active disease phases. Medical staff utilized abdominal echography and computed tomography to screen for potential tumor locations. Pathologists performed histological evaluations on tissue samples obtained through liver biopsies. The study design incorporated a retrospective review of all biochemical and imaging data gathered during the patient's life. Researchers conducted an extensive post-mortem examination to resolve the diagnostic uncertainty regarding the primary tumor site. This comprehensive methodology allowed for the correlation of clinical symptoms with final anatomical findings.
Main Results:
Key findings from the literature indicate that cortisol levels varied erratically from normal to extremely high values throughout the observation period. During active hypersecretion, the patient demonstrated a complete lack of suppression by high doses of dexamethasone. Conversely, the patient displayed normal circadian rhythmicity and appropriate responses to hypoglycemia during intervals of hormonal dormancy. The clinical team observed no development of hypokalemia, which is often associated with ectopic hormone excess. Imaging detected liver masses, and subsequent biopsy analysis pointed toward a neuroendocrine tumor of foregut origin. Despite the initial focus on the liver, detailed post-mortem studies identified the pancreatic tail as the most likely primary tumor site. The researchers confirmed that the primary tumor was occult throughout the clinical course, complicating the diagnostic process. These results underscore the significant challenges in identifying ectopic sources of hormone production when secretion is intermittent.
Conclusions:
The authors propose that erratic hormone secretion patterns can mask the presence of serious neuroendocrine tumors. Synthesis and implications suggest that clinicians should maintain suspicion for occult malignancies even when biochemical markers normalize. The researchers highlight that initial imaging findings may be misleading, as seen with the liver masses in this patient. This case demonstrates that standard dexamethasone suppression tests may yield variable results depending on the timing of hormone release. The team emphasizes that identifying the primary site of ectopic hormone production often requires extensive post-mortem investigation. These findings imply that current diagnostic protocols may require refinement to better account for temporal variability in endocrine function. The authors conclude that pancreatic tumors should remain a primary consideration in cases of occult ectopic hormone production. This report serves as a reminder of the complexities involved in managing patients with non-traditional endocrine presentations.
Frequently Asked Questions
The patient exhibited erratic plasma and urinary cortisol levels, fluctuating between normal ranges and extremely high values over a ten-month period. Unlike typical cases, this individual maintained normal circadian rhythmicity and hypoglycemia responses during periods when the ectopic hormone secretion remained dormant.
Clinicians utilized echography and computed tomography scans to visualize the abdomen. These imaging tools identified liver masses, which were initially suspected as the primary site, though subsequent pathological analysis of biopsies suggested a neuroendocrine origin rather than a primary hepatic malignancy.
The researchers explain that the occult nature of the primary tumor was necessary to document, as it confounded standard diagnostic pathways. Without identifying the pancreatic tail as the true source through post-mortem study, the clinical team could not have confirmed the origin of the ectopic hormone.
Pathological examination of liver biopsies provided crucial evidence suggesting a neuroendocrine tumor of foregut origin. This data type allowed the medical team to narrow the search for the primary malignancy, even though the initial localization to the liver proved to be incorrect.
The medical team measured plasma and urinary cortisol levels at frequent intervals for over ten months. They also performed high-dose dexamethasone suppression tests, which failed to suppress cortisol during active hypersecretion phases, indicating a lack of normal feedback regulation.
The authors propose that the pancreatic tail is a more likely primary site for ectopic hormone production than the liver. They suggest that multicentric apudomas are a possible, though less probable, diagnosis compared to a singular primary tumor in the pancreas.